Kroatia - kroatia - HALMED (Agencija za lijekove i medicinske proizvode)

krewel meuselbach gmbh, krewelstrasse 2, eitorf, njemačka - gusti ekstrakt bršljanovog lista - oralne kapi, otopina - 0,04 g/ml - urbroj: 1 ml otopine (31 kap) sadrži 0,04 g ekstrakta (kao gusti ekstrakt) iz hedera helix l., folium (bršljanov list) (2,2-2,9:1); ekstrakcijsko otapalo: smjesa etanola 50 % v/v i propilenglikola u omjeru 98:2 m/m

Kroatia - kroatia - HALMED (Agencija za lijekove i medicinske proizvode)

krewel meuselbach gmbh, krewelstrasse 2, eitorf, njemačka - gusti ekstrakt bršljanovog lista - sirup - 0,8 g/100 ml - urbroj: 100 ml sirupa sadrži 0,8 g ekstrakta (kao gusti ekstrakt) iz hedera helix l., folium (bršljanov list) (2,2-2,9:1); ekstrakcijsko otapalo: smjesa etanola 50 % v/v i propilenglikola u omjeru 98:2 m/m

Euroopan unioni - kroatia - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - cistična fibroza - drugi proizvodi respiratornog sustava - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.

Euroopan unioni - kroatia - EMA (European Medicines Agency)

astrazeneca ab - durvalumab - karcinom, ne-malih stanica pluća - antineoplastična sredstva - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

Euroopan unioni - kroatia - EMA (European Medicines Agency)

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastični agensi - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

Euroopan unioni - kroatia - EMA (European Medicines Agency)

merck sharp & dohme b.v. - doravirine, lamivudin, Тенофовир дизопроксил фумарат - hiv infekcije - antivirusni lijekovi za liječenje hiv infekcija, kombinacija - delstrigo indiciran za liječenje odraslih osoba zaraženih hiv-1, bez prošlosti ili ovih dokaza otpornost do klase ННИОТ, lamivudin ili Тенофовир. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.

Euroopan unioni - kroatia - EMA (European Medicines Agency)

regeneron ireland designated activity company (dac) - cemiplimab - karcinom, squamous cell - antineoplastična sredstva - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Kroatia - kroatia - HALMED (Agencija za lijekove i medicinske proizvode)

medochemie ltd., constatinoupoleos str. 1-10, limassol, cipar - lorazepam - otopina za injekciju - 4 mg/ml - urbroj: svaka ampula sadrži 4 mg/ml lorazepama (4 mg u ampuli od 1 ml)

Kroatia - kroatia - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

ceva santé animale, 10 av. de la ballastière, 33500 libourne, francuska - inaktivirani virus reproduktivnog i respiratornog sindroma svinja (engl. porcine reproductive and respiratory syndrome, prrs), soj p120 - emulzija za injekciju - imunološki vmp - svinja (nazimice i krmače)

Kroatia - kroatia - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

genera d.d., svetonedeljska 2, kalinovica, 10436 rakov potok, hrvatska - benzatin benzilpenicilin; prokain benzilpenicilin - injekcijska suspenzija - konja, goveda, ovaca, koza, svinja, pasa i mačaka